Tango Therapeutics TNGX
NASDAQ TNGX
$26.98 +1.73 (+6.85%)
At close: Oct 21, 2026 · 4:00 PM EDT

Tango Therapeutics (TNGX) Receivables (2020 - 2022)

Updated

Tango Therapeutics' Receivables came in at $2 million for Q4 2022, unchanged from $2 million a year earlier and unchanged from the prior quarter.

Analysis

Tango Therapeutics (TNGX) Receivables (2020 - 2022) Analysis & Trends

Going back to Q4 2020, Tango Therapeutics' Receivables data covers 7 quarters.

  • Going back by year, Receivables was $2 million in FY2021 (unchanged) and $2 million in FY2020.
  • The five-year range for quarterly Receivables is $2 million (Q4 2020) to $8 million (Q3 2021).
  • Business Quant data shows TNGX's Receivables at $2 million (Q3 2022), $2 million (Q2 2022) and $2 million (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 13.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 5.06 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 12.49 Bn
10 Tango Therapeutics 4.04 Bn 2.15 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 2.00 Mn
Sep 30, 2022 2.00 Mn
Jun 30, 2022 2.00 Mn
Mar 31, 2022 2.00 Mn
Dec 31, 2021 2.00 Mn
Sep 30, 2021 8.00 Mn
Dec 31, 2020 2.00 Mn
API Access

Tango Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=TNGX&period=max&api_key=YOUR_API_KEY